Clinical trial
Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
NCT00485576 · Alexion Pharmaceuticals, Inc., Industry · Completed
Key facts
| NCT number | NCT00485576 |
|---|---|
| Title | Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma |
| Official title | A Randomized, Double Blind, Placebo-Controlled, Crossover Study to Evaluate the Safety and Efficacy of Eculizumab in Subjects With Mild Allergic Asthma. |
| Lead sponsor | Alexion Pharmaceuticals, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Allergic Asthma |
| Intervention type | Drug |
| Interventions | eculizumab |
| Enrollment | 21 |
| Start date | Sep 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jun 13, 2007 |
| Last update posted | Jan 15, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: